Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy
Top Cited Papers
- 1 February 2014
- Vol. 156 (4) , 633-648
- https://doi.org/10.1016/j.cell.2014.01.052
Abstract
No abstract availableKeywords
This publication has 162 references indexed in Scilit:
- B-cell–lineage immunogen design in vaccine development with HIV-1 as a case studyNature Biotechnology, 2012
- Outwitting Evolution: Fighting Drug-Resistant TB, Malaria, and HIVCell, 2012
- Antibody-based protection against HIV infection by vectored immunoprophylaxisNature, 2011
- Broad neutralization coverage of HIV by multiple highly potent antibodiesNature, 2011
- B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infectionNature Communications, 2010
- Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogensBiochemical and Biophysical Research Communications, 2009
- Molecular architecture of native HIV-1 gp120 trimersNature, 2008
- Autoreactivity in Human IgG+ Memory B CellsImmunity, 2007
- HIV/AIDS epidemiology, pathogenesis, prevention, and treatmentThe Lancet, 2006
- Replacing the complementarity-determining regions in a human antibody with those from a mouseNature, 1986